Bret Jensen is the lead analyst for small-cap and large-cap stocks at Investors Alley. He was recently ranked in the top 1% of contributors with Seeking Alpha and is also regular contributor to TheStreet.com's Real Money and TalkMarkets, in addition to his primary duties with Investors Alley. Formerly, Mr. Jensen was a technology director for American Express for over two decades before becoming chief investment strategist and co-founder of Simplified Asset Management, a specialty long/short hedge fund, which was ranked in the top 5% for total return during its first year. He is now the editor of Small Cap Gems, Blue Chip Gems, and Biotech Gems.
Contact Details
Tags
stock marketpharmaceuticalbiotechnologystocksinvestmentinvestingresearchpharmabiotechstock tipsanalysishealthcarebiomedicalmarket research reports
Bret Jensen is the lead analyst for small-cap and large-cap stocks at Investors Alley. He was recently ranked in the top 1% of contributors with Seeking Alpha and is also regular contributor to TheStreet.com's Real Money and TalkMarkets, in addition to his primary duties with Investors Alley. Formerly, Mr. Jensen was a technology director for American Express for over two decades before becoming chief investment strategist and co-founder of Simplified Asset Management, a specialty long/short hedge fund, which was ranked in the top 5% for total return during its first year. He is now the editor of Small Cap Gems, Blue Chip Gems, and Biotech Gems.
Tags
stock marketpharmaceuticalbiotechnologystocksinvestmentinvestingresearchpharmabiotechstock tipsanalysishealthcarebiomedicalmarket research reports
